Michael Starck
Impact in
- Hematology top 5%
- Chronic Myeloid Leukemia Treatments
- Acute Myeloid Leukemia Research
- Hematopoietic Stem Cell Transplantation
-
- Acute Lymphoblastic Leukemia research
Papers in
-
- Chronic Myeloid Leukemia Treatments 5
- Autoimmune and Inflammatory Disorders Research 2
-
- Acute Lymphoblastic Leukemia research 9
- Co-authors
- Stefan Schwartz (5 shared papers)Dieter F. Hoelzer (5 shared papers)Albrecht Reichle (3 shared papers)Andreas Viardot (3 shared papers)Nicola Gökbuget (4 shared papers)Knut Wendelin (2 shared papers)Hubert L. Serve (2 shared papers)Joachim Beck (2 shared papers)
- Journals
- Blood (4 papers)Haematologica (2 papers)Leukemia (2 papers)European Journal Of Haematology (2 papers)Journal of Hematology & Oncology (1 paper)
- Partner nations
- GermanyUnited StatesAustria
In The Last Decade
Michael Starck
18 papers receiving 699 citations
Michael Starck's Hit Papers
Peers
Comparison fields: 5 of 46
- Hematology 272
- Public Health, Environmental and Occupational Health 430
- Oncology 236
- Pediatrics, Perinatology and Child Health 140
- Genetics 70
Countries citing papers authored by Michael Starck
This map shows the geographic impact of Michael Starck's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Starck with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Starck more than expected).
Fields of papers citing papers by Michael Starck
This network shows the impact of papers produced by Michael Starck. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Starck. The network helps show where Michael Starck may publish in the future.
Co-authors
The 25 scholars most cited alongside Michael Starck, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Outcome of relapsed adult lymphoblastic leukemia depends on response to salvage chemotherapy, prognostic factors, and performance of stem cell transplantation Hit paper breakdown → | 2012 | 383 |
| 2 | 2012 | 70 | |
| 3 | 2013 | 48 | |
| 4 | 2020 | 33 | |
| 5 | 2013 | 30 | |
| 6 | 2017 | 24 | |
| 7 | 2019 | 23 | |
| 8 | 2014 | 22 | |
| 9 | 2005 | 18 | |
| 10 | Preoperative systemic etoposide/ifosfamide/doxorubicin chemotherapy combined with regional hyperthermia in high-risk sarcoma: a pilot study. | 1993 | 17 |
| 11 | 2022 | 16 | |
| 12 | 2014 | 7 | |
| 13 | 2023 | 7 | |
| 14 | 2024 | 5 | |
| 15 | 2023 | 4 | |
| 16 | 2020 | 3 | |
| 17 | 2014 | 2 | |
| 18 | 2022 | 1 | |
| 19 | 2026 | 0 |
About Michael Starck
Michael Starck is a scholar working on Hematology, Public Health, Environmental and Occupational Health, Immunology, Nephrology and Genetics, having authored 19 papers that have together received 713 indexed citations. Recurring topics across this work include Acute Lymphoblastic Leukemia research (9 papers), Chronic Myeloid Leukemia Treatments (5 papers), Renal Diseases and Glomerulopathies (3 papers), Complement system in diseases (3 papers), Childhood Cancer Survivors' Quality of Life (2 papers), Autoimmune and Inflammatory Disorders Research (2 papers), Lymphoma Diagnosis and Treatment (2 papers) and Sarcoma Diagnosis and Treatment (1 paper). The work is most often cited by research in Hematology (272 citations), Public Health, Environmental and Occupational Health (430 citations), Oncology (236 citations), Pediatrics, Perinatology and Child Health (140 citations) and Genetics (70 citations). Michael Starck has collaborated with scholars based in Germany, United States and Austria. Frequent co-authors include Stefan Schwartz, Dieter F. Hoelzer, Albrecht Reichle, Andreas Viardot, Nicola Gökbuget, Knut Wendelin, Hubert L. Serve, Joachim Beck, Matthias Stelljes and Reingard Stuhlmann. Their work appears in journals such as Blood, Haematologica, Leukemia, European Journal Of Haematology and Journal of Hematology & Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.